Giant cell myositis associated with metastatic thymoma and granulomatous hypercalcaemia.
Jessica C JimenezCalixto-Hope G LucasSara C LaHueBradley A SharpePublished in: BMJ case reports (2022)
Giant cell myositis (GCM) is a rare inflammatory myopathy associated with myasthenia gravis and thymoma. Here, we report on a woman in her late 50s with a history of myasthenia gravis, systemic lupus erythematosus and stage IV thymoma with pleural metastases, who presented with proximal weakness, neuromuscular respiratory failure and hypercalcaemia. She was diagnosed with GCM via muscle biopsy and screened for myocarditis but showed no evidence of myocardial involvement. Her hypercalcaemia was consistent with a granulomatous process, likely driven by her GCM. Her strength gradually improved, and her hypercalcaemia did not recur after treatment with high dose steroids, intravenous immune globulin and plasma exchange. Her course was complicated by several opportunistic infections in the setting of her immunosuppression. Despite the high morbidity associated with GCM, she demonstrated clinical improvement after initiating immunosuppressive therapy and continues to be managed in the outpatient setting.
Keyphrases
- myasthenia gravis
- smoking cessation
- giant cell
- high dose
- respiratory failure
- systemic lupus erythematosus
- interstitial lung disease
- extracorporeal membrane oxygenation
- low dose
- squamous cell carcinoma
- mechanical ventilation
- stem cell transplantation
- small cell lung cancer
- oxidative stress
- left ventricular
- disease activity
- skeletal muscle
- ultrasound guided
- case report
- rheumatoid arthritis
- late onset
- mesenchymal stem cells
- early onset
- idiopathic pulmonary fibrosis